Triple Antithrombotic Therapy for Atrial Fbrillation and Coronary Stents

Authors

  • Avazbekov B. A. Department of faculty therapy Andijan state medical institute
  • Kodirov. Kh. N. Department of faculty therapy Andijan state medical institute
  • Kodirova G. I. Department of faculty therapy Andijan state medical institute
  • Qandilbekov D. Department of faculty therapy Andijan state medical institute

Keywords:

acute coronary syndrome, atrial fibrillation, oral anticoagulants, antiplatelet drugs

Abstract

Information on combined anticoagulant and antiplatelet treatment in patients with intense coronary disorder and atrial fibrillation has been displayed. Issues laid out within the Rules and Agreement archives on the treatment of patients with atrial fibrillation, intense coronary disorder, myocardial revascularization, the utilize of unused verbal anticoagulants, which examines double and triple antithrombotic treatment, have been considered.

Downloads

Published

2022-11-13

How to Cite

B. A., A. ., Kh. N., K. ., G. I., K. ., & D., Q. . (2022). Triple Antithrombotic Therapy for Atrial Fbrillation and Coronary Stents. Vital Annex: International Journal of Novel Research in Advanced Sciences, 1(5), 39–44. Retrieved from https://innosci.org/IJNRAS/article/view/439

Issue

Vol. 1 No. 5 (2022): November 2022

Section

Articles